The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patientsSusanna Leskelä, Cristina Rodríguez‐Antona, Marta Mendiola et al.|Endocrine Related Cancer|2010Cited by 207